New Products & Services

Hansa Biopharma announces positive reimbursement decision for Idefirix (imlifidase) in Belgium as desensitization treatment for highly sensitized patients in kidney transplantation

by

LUND, Sweden, June 1, 2023 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that it has attained reimbursement in Belgium for its first-in-class treatment, Idefirix, for the desensitization treatment of highly sensitized adult patients prior to kidney transplant from a deceased donor. Idefirix is available … Read more

ASICS REACHES NEW LEVELS OF COMFORT FOR A STABILITY SHOE WITH THE LANDMARK GEL-KAYANO™ 30

by

Latest iteration of the iconic GEL-KAYANO™ series combines market-leading stability with unprecedented levels of comfort. This is achieved through new 4D GUIDANCE SYSTEM™ technology that provides adaptive stability for the runner by adjusting to pronation changes throughout the run. The new GEL-KAYANO™ 30 running shoe will be available instore and online globally from June 2023. … Read more

Medline adds award-winning IDENTI medical sensing solutions to its supply chain portfolio

by

Offers first wireless weight-based PAR bins in the U.S. NORTHFIELD, Ill., May 31, 2023 /PRNewswire/ — Responding to increased healthcare provider demand for digital and scalable inventory management solutions, Medline has enhanced its supply chain optimization (SCO) portfolio with a new partnership with IDENTI Medical.   Medline adds healthcare supply chain optimization solutions, including first … Read more

How Much Should You Save for Retirement, Professional Stuntmen Offer Tips on Falling Safely, Fraud-Proofing Your Wallet, and Staying Safe This Summer

by

WASHINGTON, May 31, 2023 /PRNewswire/ — The June issue of AARP Bulletin offers readers critical stories and news updates – from an illustrated guide from the stuntmen on the new Indiana Jones movie on avoiding injury when falling to calculating how much money you’ll need for retirement. The following are highlights from this month’s Bulletin: Cover Story: How to Stay … Read more

IrisGuard and NassWallet partner in Iraq to help UNHCR provide EyePay® service through mobile money transfer for refugees in need

by

Iris-enabled digital payment services expand in Iraq by integrating with NassWallet for secure and convenient usage by refugees.  LONDON and ERBIL, Iraq, May 30, 2023 /PRNewswire/ — Today, IrisGuard and NassWallet announced a new partnership with the integration and deployment of the award-winning IrisGuard EyePay® iris enabled smartphone, EyeCloud ® platform with NassWallet’s mobile wallet service. … Read more

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand USA – English USA – English

by

MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in … Read more

Se otorga la cuarta aprobación IDE de Concept Medical para el balón recubierto de sirolimus MagicTouch para el tratamiento de la enfermedad de la arteria femoral superficial (SFA) USA – español USA – English USA – English USA – Deutsch

by

TAMPA, Fla., 30 de mayo de 2023 /PRNewswire/ — El 24 de mayo de 2023, la FDA de EE.UU. otorgó una exención de dispositivo de investigación (IDE) para el balón recubierto de sirolimus (SCB) MagicTouch PTA de Concept Medical Inc para el tratamiento de las arterias femorales superficiales (SFA). Esto marca la cuarta aprobación de IDE para el balón … Read more

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

by

TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch  PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has … Read more

Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency

by

SAN DIEGO, May 29, 2023 /PRNewswire/ — Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS. This highly competitive grant will provide substantial funding for the advancement of AMP-201, an AAV-ColQ gene … Read more

Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive Effect Protecting DNA From Radiation Exposure

by

TORONTO, May 27, 2023 /PRNewswire/ — Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR, Founder, Inventor, and CMO of Cora Therapeutics, announced the efficacy of a … Read more